Estimaciones de analistas de Wall Street para Q32 Bio Inc. (QTTB): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.36 | ||
| 2026-08-05 | $-0.44 | $-0.46 | +4.3% |
| 2026-05-05 | $-0.54 | $-0.68 | +20.6% |
| 2026-03-10 | $3.65 | $-0.85 | +529.4% |
| 2025-11-13 | $-0.60 | $-1.39 | +56.8% |
| 2025-08-06 | $-0.78 | $-1.14 | +31.6% |
| 2025-05-08 | $-0.90 | $-1.23 | +26.8% |
| 2025-03-11 | $-1.16 | $-1.25 | +7.2% |
Ratios de valoración
| Ratio P/E | 3.84 |
| Precio / Valor contable | 1.42 |
| EV / EBITDA | 7.13 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $5.3M | $1.7M | $2.7M | 0 | $6.7M | -$6.7M | 0 | $53.7M |
| Coste de Ventas | $239797 | $684214 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$239797 | -$684214 | $5.3M | $1.7M | 0 | 0 | $6.7M | -$6.7M | 0 | $53.7M |
| I+D | $5.7M | $21.4M | $47.9M | $89.4M | $100.4M | $29.9M | $35.8M | $31.7M | $48.1M | $19.2M |
| Generales y Administrativos | $4.1M | $7.6M | $16.0M | $15.9M | $23.7M | $6.8M | $10.1M | $9.9M | $18.0M | $17.7M |
| Gastos Operativos | $9.8M | $29.0M | $64.0M | $105.3M | $124.1M | $36.7M | $45.9M | $41.6M | $66.1M | $36.8M |
| Beneficio Operativo | -$10.0M | -$29.7M | -$59.9M | -$109.9M | -$130.3M | -$36.7M | -$39.2M | -$48.3M | -$66.1M | $16.9M |
| EBITDA | -$7.8M | -$29.3M | -$58.6M | -$97.6M | -$121.4M | -$36.6M | -$38.9M | -$47.8M | -$44.5M | $31.3M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M | $1.1M |
| Beneficio Antes de Impuestos | -$8.0M | -$30.0M | -$55.6M | -$103.9M | -$128.7M | -$37.0M | -$42.7M | -$53.4M | -$47.7M | $29.8M |
| Impuestos | $2 | -$4 | 0 | 0 | 0 | $547000 | $62000 | $318000 | $21000 | 0 |
| Beneficio Neto | -$8.0M | -$30.0M | -$55.6M | -$103.9M | -$128.7M | -$37.6M | -$42.8M | -$53.7M | -$47.7M | $29.8M |
| BPA | $-3.87 | $-14.42 | $-35.04 | $-44.41 | $-50.46 | $-3.15 | $-3.59 | $-4.51 | $-5.12 | $2.42 |
| BPA Diluido | $-3.87 | $-14.42 | $-35.04 | $-44.41 | $-50.46 | $-3.15 | $-3.59 | $-4.51 | $-6.58 | $2.42 |
| Acciones en Circulación (Diluidas) | $2.1M | $2.1M | $1.6M | $2.3M | $2.6M | $11.9M | $11.9M | $11.9M | $9.7M | $12.3M |
Precio
| Precio | $10.98 |
| Capitalización | $327M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANTX · BOLD · GBIO · INTS · ITRM · NXTC · PSTV
Explorar sector: Healthcare · Biotechnology
Más secciones de QTTB: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones